Free Trial
NASDAQ:EZRA

Ezra Q2 2026 Earnings Results & Report

Ezra logo
$2.28 -0.20 (-8.06%)
Closing price 10/16/2026 04:00 PM Eastern
Extended Trading
$2.28 +0.01 (+0.22%)
As of 10/16/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ezra reported Q2 2026 earnings on July 30, 2026. The company reported EPS of -$3.26, while revenue was $2.11 million.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
After Market Closes

Ezra EPS Results

Actual EPS
-$3.26
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Ezra Revenue Results

Actual Revenue
$2.11 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Ezra Q2 2026 Earnings FAQ

Ezra (NASDAQ:EZRA) reported earnings of -$3.26 per share for Q2 2026. The report was announced on Thursday, July 30, 2026.

Ezra reported revenue of $2.11 million for Q2 2026.

Ezra Earnings Headlines

My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.tc pixel
See More Ezra Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ezra? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ezra and other key companies, straight to your email.

About Ezra

Ezra (NASDAQ:EZRA) (NASDAQ: EZRA) is a health care technology company focused on improving cancer screening and early detection. The company combines magnetic resonance imaging (MRI) with artificial intelligence to help identify potential cancer and other abnormalities, with the goal of making screening more accessible, efficient and comprehensive.

Its services include Ezra Screen, an MRI-based screening program designed to examine multiple areas of the body in a single session, as well as related imaging and cancer-screening services. Ezra’s artificial intelligence tools are intended to assist radiologists in reviewing scans and identifying findings that may require further evaluation; they are not a substitute for a physician’s diagnosis.

Ezra was founded in 2018 by Emi Gal, who has served as the company’s chief executive officer. The company’s screening services are offered through a network of imaging centers in the United States. Availability and the specific services provided may vary by location and applicable medical and regulatory requirements.

View Ezra Profile